Octreotide Acetate Injection, Solution
Product Images NDC 25021-463

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 25021-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Oct05 0003 01)

The text seems to be a chemical compound's formula consisting of amino acids. Specifically, it is the formula for H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol which includes 10 amino acids. The additional characters "xCH;COOH where 14t02.5" are not clear and may be an error in the .*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 02)

The text describes a medication with the National Drug Code (NDC) 25021-466-05 named Octreotide Acetate Injection. It contains 1 milligram (mcg) per 5 milliliters (mL), which is equivalent to 200 micrograms per milliliter (mL).*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 03)

This appears to be a product description for a 5,000 mg/mL multi-dose vial of octreotide acetate injection for subcutaneous injection, with an NDC number of 25021-467-05. The document also includes some seemingly unrelated text that does not appear to be relevant or understandable, likely due to errors in (optical character recognition) processing.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 04)

This is a description of Octreotide Acetate Injection, a pharmaceutical product that comes in a 1 mL Single-Dose Vial, produced by SAGENT Pharmaceuticals. It is meant for subcutaneous injection and contains 1 mcg (base) per mL. The product is made in Canada and the packaging contains the NDC code 25021-463-01. However, there is a typo in the first line where there is a space between the "&" and "nly" which could indicate that there may have been some formatting errors during the process.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 05)

This is a description of a pharmaceutical product, specifically a 1 mL single-dose vial of Octreotide Acetate Injection with a concentration of 100 mcg (base) per mL. The NDC number is 25021-464-01, and the product is made in Canada by an unknown pharmaceutical company that was manufactured for SAGENT. The text also includes instructions to discard unused portions.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 06)

NDC 25021-465-01 is a prescription drug indicated for subcutaneous injection. It contains Octreotide Acetate Injection at a concentration of 500 mcg (base) per mL. The drug is a pharmaceutical product manufactured in Canada and it is available in a single-dose vial of 1 mL. No additional information can be provided due to the presence of non-English characters in the output.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.